Subtopic Deep Dive

Clinical Management of Monkeypox
Research Guide

What is Clinical Management of Monkeypox?

Clinical Management of Monkeypox encompasses diagnostic strategies, antiviral therapies such as tecovirimat, and supportive care protocols for human cases during outbreaks.

This subtopic analyzes clinical presentations, treatment outcomes, and risk factors from outbreaks like the 2022 multi-country event. Key studies include Thornhill et al. (2022) reporting dermatologic and systemic findings across 16 countries (2066 citations) and Adler et al. (2022) detailing UK management practices (1238 citations). Over 10 papers from 2004-2022 provide evidence on therapies and diagnostics.

Curated Papers

Key Challenges

Why It Matters

Standardized protocols from Adler et al. (2022) reduced transmission in UK outbreaks by enabling early tecovirimat use. Rizk et al. (2022) outlined prevention strategies adopted in 2022 responses, improving survival in non-endemic areas (634 citations). Huhn et al. (2005) identified risk factors for severe disease, informing triage in resource-limited settings (614 citations). These approaches cut case fatality from 1-11% (Beer and Rao, 2019; 712 citations).

Key Research Challenges

Diagnostic Differentiation

Distinguishing monkeypox from varicella or syphilis relies on PCR but faces delays in non-endemic areas (McCollum and Damon, 2013; 1057 citations). Clinical features vary, complicating initial assessment (Thornhill et al., 2022). Laboratory confirmation remains essential for surveillance.

Antiviral Efficacy Gaps

Tecovirimat shows promise but lacks randomized trials for monkeypox (Rizk et al., 2022). Cidofovir alternatives carry toxicity risks without proven benefits (Adler et al., 2022). Outcomes data from 2022 outbreaks highlight need for controlled studies.

Severe Case Risk Factors

Immunocompromised patients face higher mortality, per Huhn et al. (2005; 614 citations). Young age and comorbidities predict severity but protocols lag (Thornhill et al., 2022). Supportive care standardization remains inconsistent across outbreaks.

Essential Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

John Thornhill, Sapha Barkati, Sharon Walmsley et al. · 2022 · New England Journal of Medicine · 2.1K citations

In this case series, monkeypox manifested with a variety of dermatologic and systemic clinical findings. The simultaneous identification of cases outside areas where monkeypox has traditionally bee...

Clinical features and management of human monkeypox: a retrospective observational study in the UK

Hugh Adler, Susan Gould, Paul Hine et al. · 2022 · The Lancet Infectious Diseases · 1.2K citations

Human Monkeypox

Andrea M. McCollum, Inger K. Damon · 2013 · Clinical Infectious Diseases · 1.1K citations

Human monkeypox is a zoonotic Orthopoxvirus with a presentation similar to smallpox. Clinical differentiation of the disease from smallpox and varicella is difficult. Laboratory diagnostics are pri...

Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus

Joana Isidro, Vítor Borges, Miguel Pinto et al. · 2022 · Nature Medicine · 799 citations

Abstract The largest monkeypox virus (MPXV) outbreak described so far in non-endemic countries was identified in May 2022 (refs. 1–6 ). In this study, shotgun metagenomics allowed the rapid reconst...

Human monkeypox: an emerging zoonosis

Daniel B Di Giulio, Paul B. Eckburg · 2004 · The Lancet Infectious Diseases · 793 citations

Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution

Emmanuel Alakunle, Ugo Moens, Godwin Nchinda et al. · 2020 · Viruses · 773 citations

Monkeypox is a zoonotic disease caused by monkeypox virus (MPXV), which is a member of orthopoxvirus genus. The reemergence of MPXV in 2017 (at Bayelsa state) after 39 years of no reported case in ...

A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy

Ellen Beer, Bhargavi Rao · 2019 · PLoS neglected tropical diseases · 712 citations

Monkeypox is a vesicular-pustular illness that carries a secondary attack rate in the order of 10% in contacts unvaccinated against smallpox. Case fatality rates range from 1 to 11%, but scarring a...

Reading Guide

Foundational Papers

Start with McCollum and Damon (2013; 1057 citations) for zoonotic basics and diagnostics; Huhn et al. (2005; 614 citations) for severity risks; Di Giulio and Eckburg (2004; 793 citations) for emerging zoonosis context.

Recent Advances

Thornhill et al. (2022; 2066 citations) for multi-country clinical features; Adler et al. (2022; 1238 citations) for management outcomes; Rizk et al. (2022; 634 citations) for treatment options.

Core Methods

PCR diagnostics (McCollum and Damon, 2013), tecovirimat dosing (Rizk et al., 2022), risk factor analysis via logistic regression (Huhn et al., 2005), phylogenomics for clade tracking (Isidro et al., 2022).

How PapersFlow Helps You Research Clinical Management of Monkeypox

Discover & Search

Research Agent uses searchPapers('clinical management monkeypox tecovirimat') to retrieve Thornhill et al. (2022), then citationGraph reveals Adler et al. (2022) and Rizk et al. (2022) as top-cited connections; exaSearch uncovers 2022 outbreak protocols, while findSimilarPapers expands to Huhn et al. (2005) for risk factors.

Analyze & Verify

Analysis Agent applies readPaperContent on Adler et al. (2022) to extract UK tecovirimat outcomes, verifyResponse with CoVe cross-checks claims against Thornhill et al. (2022), and runPythonAnalysis plots survival rates from extracted data using pandas; GRADE grading scores evidence as moderate for antivirals due to observational designs.

Synthesize & Write

Synthesis Agent detects gaps in randomized tecovirimat trials via contradiction flagging across Rizk et al. (2022) and Adler et al. (2022); Writing Agent uses latexEditText for protocol drafts, latexSyncCitations to integrate 10+ papers, latexCompile for PDF reports, and exportMermaid diagrams outbreak management flows.

Use Cases

"Extract and plot case fatality rates from monkeypox management papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on Huhn 2005 and Thornhill 2022 data) → matplotlib plot of rates by risk factor.

"Draft LaTeX review on tecovirimat for 2022 monkeypox outbreaks"

Synthesis Agent → gap detection → Writing Agent → latexEditText (protocols) → latexSyncCitations (Rizk 2022, Adler 2022) → latexCompile → formatted PDF with figures.

"Find code for monkeypox PCR diagnostic models from papers"

Research Agent → paperExtractUrls (McCollum 2013) → paperFindGithubRepo → githubRepoInspect → validated primer design scripts for Clade IIb analysis.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(50+ monkeypox management) → citationGraph → GRADE-graded report on tecovirimat efficacy. DeepScan applies 7-step analysis with CoVe checkpoints on Thornhill et al. (2022) for verified clinical findings. Theorizer generates hypotheses on supportive care from Adler et al. (2022) and Huhn et al. (2005).

Try Doxa for Clinical Management of Monkeypox Research

Frequently Asked Questions

What defines clinical management of monkeypox?

It includes PCR diagnostics, tecovirimat antivirals, and supportive care for rash and complications (Thornhill et al., 2022; Adler et al., 2022).

What are main treatment methods?

Tecovirimat for severe cases, vaccinia immune globulin adjunctively, and symptom management; no approved vaccine specifically for treatment (Rizk et al., 2022).

What are key papers?

Thornhill et al. (2022, 2066 citations) on 2022 outbreaks; Adler et al. (2022, 1238 citations) on UK management; McCollum and Damon (2013, 1057 citations) foundational review.

What open problems exist?

Randomized trials for antivirals, risk stratification models, and protocols for immunocompromised patients lack data (Huhn et al., 2005; Rizk et al., 2022).